10.30 USD
↗ 0.22 (2.18%)AT CLOSE (03:59 PM EST)
Keros Therapeutics, Inc. Common Stock
KROSNASDAQ • USD
10.33
↗ 0.03 (0.24%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
10.33
↗ 0.03 (0.24%)
Market: CLOSED
KROS is currently priced at $10.30. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Nov 13, 2026.
Open?$10.06
High?$10.55
Low?$9.55
Prev. Close?$10.08
Volume?167.0K
Avg. Volume?184.6K
VWAP?$10.14
Rel. Volume?0.91x
Bid / Ask
Bid?$8.50 × 100
Ask?$10.87 × 100
Spread?$2.37
Midpoint?$9.68
Valuation & Ratios
Market Cap?202.1M
Shares Out?19.6M
Float?18.5M
Float %?93.1%
P/E Ratio?N/A
P/B Ratio?0.72
EPS?-$3.15
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
Employees
92
Market Cap
202.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-04-08
Address
1050 WALTHAM STREET, SUITE 302
LEXINGTON, MA 02421
Phone: 617-314-6297
LEXINGTON, MA 02421
Phone: 617-314-6297
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?47
Momentum?8
Short Sent.?63
Piotroski F-Score?4/9Mixed
Altman Z-Score?2.33Grey
Confidence?56%Low
Short InterestHigh
Short % of Float?5.89%Elevated
Short Interest?1.1M
Days to Cover?7.1
Free Float18.5M
Avg Daily Volume153.9K
Settlement Date2026-10-30
Financial Health
Current Ratio?18.14Strong
Quick Ratio?18.14Strong
Cash Ratio?16.36Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?0.72CHEAP▾
Peers100
S&P97
P/S?4.96FAIR▾
Peers100
S&P29
P/FCF?N/A▾
EV/EBITDA?0.8CHEAP▾
Peers100
S&P97
EV/Sales?-1.41CHEAP▾
S&P97
Returns & Efficiency
ROE?-22.1%WEAK▾
S&P7
ROA?-20.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-48273000
Enterprise Value?$-57332948
Fundamentals ratios updated end of day